Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

The End Of The Line For Existing Stem Cell Research?
Time is short for scientists to respond to the call for comments on the National Institutes of Health (NIH) proposed guidelines for the use of human embryonic stem (ES) cell lines and their eligibility for federal funds. On May 26, the window to provide feedback will close, and the drafted rules leave the possibility that funding for almost all existing cell lines will disappear.
generic viagra online
Hormone Therapy May Confer More Aggressive Properties To Prostate Tumours
Hormone therapy is often given to patients with advanced prostate cancer. While it is true that the treatment prevents growth of the tumour, it also changes its properties. Some of these changes may result in the tumour becoming more aggressive and more liable to form metastases. This is one of the conclusion of a thesis presented at the Sahlgrenska Academy.
News of the day
Livestrong(R) Global Cancer Campaign Announces Groundbreaking New European Commitments To Cancer Control
Today the Lance Armstrong Foundation (LAF) announced outstanding new commitments to cancer control from European nations including Belgium, England, Germany, Ireland and Italy as part of the LIVESTRONG Global Cancer Campaign, an initiative to address the global cancer burden. The European commitments feature ambitious goals ranging from creating a national cancer plan to addressing disparities in treatment for cancer survivors to establishing an academy devoted entirely to cancer to improvements for breast health services, among others.
Endocrinology

Three New Studies Give Clear Guidance On How To Better Recruit Volunteers For Alzheimer's Clinical Studies

Partnering with local physicians, working with local clinics, conducting educational seminars and health fairs were found to be the most effective tools in recruiting people for clinical studies "Clinical trials are very important. Not only do they drive forward dementia research but people who participate in clinical trials often experience positive benefits. Despite this a very small number of people are given the opportunity to participate in a dementia research trial. We must invest in clinical trials and use the unique value of the NHS to improve patient access to clinical trials. This will allow new treatments to reach people with dementia as soon as possible. "Communication is also key. It is important to ensure that people are given practical information about available trials and realistic advice about selection." Professor Clive Ballard Director of Research Alzheimer"s Society Notes - International Conference of Alzheimer"s Disease runs from 11 - 16 July 2009 for further information please visit ICAD - One in three people over 65 will die with dementia - Alzheimer"s Society research shows that 700,000 people in the UK have a form of dementia, more than half have Alzheimer"s disease. In less than 20 years nearly a million people will be living with dementia. This will soar to 1.7 million people by 2051. - Alzheimer"s Society champions the rights of people living with dementia and the millions of people who care for them. - Alzheimer"s Society works in England, Wales and Northern Ireland - Alzheimer"s Society needs to raise money to help people live well with dementia today and for research to find a cure for tomorrow. You can donate now by calling 0845 306 0898 or visiting http://www.alzheimers.org.uk Alzheimer"s Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009